Education
About Us
Working with TipRanks
Follow Us
Q-linea AB (SE:QLINEA)
:QLINEA
QLINEA Stock Chart & Stats
kr22.36
>-kr0.01(-3.85%)
At close: 4:00 PM EST
kr22.36
>-kr0.01(-3.85%)
Day’s Range― - ―
52-Week Rangekr23.41 - kr920.79
Previous CloseN/A
Volume6.05M
Average Volume (3M)13.43K
Market Cap
kr416.36M
Enterprise Valuekr254.53M
Total Cash (Recent Filing)kr42.58M
Total Debt (Recent Filing)kr47.86M
Price to Earnings (P/E)―
Beta3.31
Next Earnings
Feb 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.12
Shares Outstanding18,949,081
10 Day Avg. Volume10,725
30 Day Avg. Volume13,430
Financial Highlights & Ratios
PEG Ratio28.47
Price to Book (P/B)-20.81K
Price to Sales (P/S)241908.43
P/FCF Ratio-3.05K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Q-linea AB News
QLINEA FAQ
What was Q-linea AB’s price range in the past 12 months?
Q-linea AB lowest stock price was kr23.41 and its highest was kr920.79 in the past 12 months.
What is Q-linea AB’s market cap?
Q-linea AB’s market cap is kr416.36M.
When is Q-linea AB’s upcoming earnings report date?
Q-linea AB’s upcoming earnings report date is Feb 04, 2026 which is in 41 days.
How were Q-linea AB’s earnings last quarter?
Q-linea AB released its earnings results on Oct 30, 2025. The company reported -kr6.121 earnings per share for the quarter, missing the consensus estimate of N/A by -kr6.121.
Is Q-linea AB overvalued?
According to Wall Street analysts Q-linea AB’s price is currently Overvalued.
Does Q-linea AB pay dividends?
Q-linea AB does not currently pay dividends.
What is Q-linea AB’s EPS estimate?
Q-linea AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Q-linea AB have?
Q-linea AB has 18,949,081 shares outstanding.
What happened to Q-linea AB’s price movement after its last earnings report?
Q-linea AB reported an EPS of -kr6.121 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.354%.
Which hedge fund is a major shareholder of Q-linea AB?
Currently, no hedge funds are holding shares in SE:QLINEA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Q-linea AB
Q-linea AB (QLINEA) is a biotechnology company based in Sweden, focused on developing innovative diagnostic solutions for healthcare. The company specializes in advanced technologies for microbial detection and antibiotic susceptibility testing, primarily targeting the areas of infectious diseases and personalized medicine. Q-linea's core products include the ASTar system, a rapid diagnostic platform that offers precise identification and susceptibility profiling of pathogens, enabling healthcare providers to make informed treatment decisions quickly.
Technical Analysis
Vicore Pharma Holding AB
―
Isofol Medical AB
―
Biovica International AB Class B
―
Doxa AB
―
Guard Therapeutics International AB
―